These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 18063294)

  • 1. Bacterial targeted tumour therapy-dawn of a new era.
    Wei MQ; Mengesha A; Good D; Anné J
    Cancer Lett; 2008 Jan; 259(1):16-27. PubMed ID: 18063294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New strategies for cancer gene therapy: progress and opportunities.
    Cao S; Cripps A; Wei MQ
    Clin Exp Pharmacol Physiol; 2010 Jan; 37(1):108-14. PubMed ID: 19671071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facultative or obligate anaerobic bacteria have the potential for multimodality therapy of solid tumours.
    Wei MQ; Ellem KA; Dunn P; West MJ; Bai CX; Vogelstein B
    Eur J Cancer; 2007 Feb; 43(3):490-6. PubMed ID: 17113280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of bacteria in anti-cancer therapies.
    Ryan RM; Green J; Lewis CE
    Bioessays; 2006 Jan; 28(1):84-94. PubMed ID: 16369949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacteria in the treatment of cancer.
    Lin J; Lin E; Nemunaitis J
    Curr Opin Mol Ther; 2004 Dec; 6(6):629-39. PubMed ID: 15663328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterial vectors and delivery systems in cancer therapy.
    Gardlik R; Fruehauf JH
    IDrugs; 2010 Oct; 13(10):701-6. PubMed ID: 20878592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hypoxia in malignant tumors the target for clostridial therapeutic gene strategies].
    Wallner G; Misiuna P; Cygan W; Cygan Z
    Pol Merkur Lekarski; 2005 Aug; 19(110):242-4. PubMed ID: 16245444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radio-responsive recA promoter significantly increases TNFalpha production in recombinant clostridia after 2 Gy irradiation.
    Nuyts S; Van Mellaert L; Theys J; Landuyt W; Bosmans E; Anné J; Lambin P
    Gene Ther; 2001 Aug; 8(15):1197-201. PubMed ID: 11509951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The tumour-Clostridium phenomenon: 50 years of developmental research (Review).
    Schmidt W; Fabricius EM; Schneeweiss U
    Int J Oncol; 2006 Dec; 29(6):1479-92. PubMed ID: 17088987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clostridial spores to treat solid tumours - potential for a new therapeutic modality.
    Mengesha A; Wei JZ; Zhou SF; Wei MQ
    Curr Gene Ther; 2010 Feb; 10(1):15-26. PubMed ID: 20158471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of clostridial spores for cancer treatment.
    Barbé S; Van Mellaert L; Anné J
    J Appl Microbiol; 2006 Sep; 101(3):571-8. PubMed ID: 16907807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Live bacteria as the basis for immunotherapies against cancer.
    Chabalgoity JA; Dougan G; Mastroeni P; Aspinall RJ
    Expert Rev Vaccines; 2002 Dec; 1(4):495-505. PubMed ID: 12901588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Le morte du tumour: histological features of tumor destruction in chemo-resistant cancers following intravenous infusions of pathotropic nanoparticles bearing therapeutic genes.
    Gordon EM; Chan MT; Geraldino N; Lopez FF; Cornelio GH; Lorenzo CC; Levy JP; Reed RA; Liu L; Hall FL
    Int J Oncol; 2007 Jun; 30(6):1297-307. PubMed ID: 17487349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clostridia in cancer therapy.
    Minton NP
    Nat Rev Microbiol; 2003 Dec; 1(3):237-42. PubMed ID: 15035028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clostridium-mediated transfer system of therapeutic proteins to solid tumors: increased heterologous protein production.
    Barbé S; Van Mellaert L; Anné J
    Commun Agric Appl Biol Sci; 2004; 69(2):49-52. PubMed ID: 15560185
    [No Abstract]   [Full Text] [Related]  

  • 16. Clostridium spores as anti-tumour agents.
    Van Mellaert L; Barbé S; Anné J
    Trends Microbiol; 2006 Apr; 14(4):190-6. PubMed ID: 16500103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural and genetically engineered viral agents for oncolysis and gene therapy of human cancers.
    Sinkovics JG; Horvath JC
    Arch Immunol Ther Exp (Warsz); 2008 Dec; 56 Suppl 1():3s-59s. PubMed ID: 19104757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene therapy for cancer: bacteria-mediated anti-angiogenesis therapy.
    Gardlik R; Behuliak M; Palffy R; Celec P; Li CJ
    Gene Ther; 2011 May; 18(5):425-31. PubMed ID: 21228886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clostridium as a tumor-specific delivery system of therapeutic proteins.
    Theys J; Landuyt AW; Nuyts S; Van Mellaert L; Lambin P; Anné J
    Cancer Detect Prev; 2001; 25(6):548-57. PubMed ID: 12132875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic Potential of
    Sharafabad BE; Abdoli A; Abdolmohammadi Khiav L; Meskini M; Jamur P; Dilmaghani A
    Curr Cancer Drug Targets; 2023; 23(9):682-696. PubMed ID: 37069721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.